Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Vivos Therapeutics (VVOS) Shares Issued (2020 - 2025)

Vivos Therapeutics' Shares Issued history spans 5 years, with the latest figure at $4.7 million for Q4 2025.

  • Quarterly results put Shares Issued at $4.7 million for Q4 2025, up 34.57% from a year ago — trailing twelve months through Dec 2025 was $10.6 million (down 3.55% YoY), and the annual figure for FY2025 was $5.6 million, down 25.65%.
  • Shares Issued for Q4 2025 was $4.7 million at Vivos Therapeutics, up from $2.4 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $8.0 million in Q1 2023 to a low of -$4.0 million in Q4 2023.
  • The 4-year median for Shares Issued is $3.5 million (2024), against an average of $2.5 million.
  • Peak annual rise in Shares Issued hit 187.5% in 2024, while the deepest fall reached 50.74% in 2024.
  • Year by year, Shares Issued stood at $330000.0 in 2021, then crashed by 1312.12% to -$4.0 million in 2023, then surged by 187.5% to $3.5 million in 2024, then skyrocketed by 34.57% to $4.7 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $4.7 million, $2.4 million, and $3.5 million for Q4 2025, Q3 2025, and Q4 2024 respectively.